sotalol has been researched along with amiodarone in 323 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (4.64) | 18.7374 |
| 1990's | 96 (29.72) | 18.2507 |
| 2000's | 143 (44.27) | 29.6817 |
| 2010's | 58 (17.96) | 24.3611 |
| 2020's | 11 (3.41) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Borggrefe, M; Breithardt, G; Haverkamp, W; Hindricks, G; Shenasa, M | 1 |
| Follath, F | 1 |
| Huikuri, HV; Yli-Mäyry, S | 1 |
| Jung, W; Lüderitz, B; Manz, M | 1 |
| Honerjäger, P; Schmidt, G | 1 |
| Arstall, MA; Hii, JT; Horowitz, JD; Lehman, RG | 1 |
| Deiwick, M; Konertz, W; Scheld, HH; Weyand, M | 1 |
| Campbell, R; Loaiza, A | 1 |
| Satoh, H | 2 |
| Crijns, HJ; Gosselink, AM; Hillege, H; Lie, KI; Van Gelder, IC; Van Gilst, WH | 1 |
| Anderson, JL | 1 |
| Hamer, A; Hunt, D; Vohra, J; Warren, R | 1 |
| Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F | 1 |
| Bauernfeind, RA; Welch, WJ | 1 |
| Hanaki, Y; Ozawa, T; Sano, T; Shimada, Y; Sugiyama, S; Taki, K | 1 |
| Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
| Vaughan Williams, EM | 1 |
| Gössinger, HD; Leitha, T; Mösslacher, H; Siostrzonek, P; Wagner, L | 1 |
| Connell, MJ; Cumiskey, WR; Dillon, KM; Ezrin, AM; Silver, PJ; Volberg, WA | 1 |
| Roden, DM; Woosley, RL | 1 |
| Nademanee, K; Singh, BN | 1 |
| Reneman, RS; Van de Water, A; Verheyen, J; Xhonneux, R | 1 |
| Dehareng, A; Kulbertus, HE; Nzayinambaho, K; Rodriguez, LM; Waleffe, A | 1 |
| Huang, SK; Marcus, FI | 1 |
| Gonzalez, R; Griffin, JC; Herre, JM; Sauve, MJ; Scheinman, MM; Sharkey, H | 1 |
| Campbell, RW | 1 |
| Camin, G; Disertori, M; Fiorentini, F; Furlanello, F; Guareneiro, M; Inama, G; Nicasi, L | 1 |
| Burckhardt, D; Hoffmann, A; White, RA | 1 |
| Bexton, RS; Camm, AJ | 1 |
| Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
| Borggrefe, M; Breithardt, G; Chen, X; Martínez-Rubio, A; Shenasa, M; Wichter, T | 1 |
| Singer, I | 1 |
| Hohnloser, SH | 2 |
| Cui, G; Sager, P; Sen, L; Singh, BN; Uppal, P | 1 |
| McCarthy, PT; O'Sullivan, JJ; Wren, C | 1 |
| Epstein, AE | 1 |
| Domanski, MJ; Epstein, AE; Greene, HL; Hallstrom, AP; Schron, EB; Wyse, DG; Zipes, D | 1 |
| Singh, BN | 5 |
| Edvardsson, N | 1 |
| Bakr, O; Daoud, E; Hummel, JD; Kou, W; Man, KC; Morady, F; Niebauer, M; Strickberger, SA; Williamson, BD | 1 |
| Chalmers, JP; McRitchie, RJ; Roberts-Thomson, P; Twidale, N | 1 |
| Holt, DW; Leatham, EW; McKenna, WJ | 1 |
| Dorian, P; Downar, E; Harris, L; Newman, D | 1 |
| Greene, HL | 1 |
| Gutiérrez-Larraya, F; Jabón, A | 1 |
| Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M | 1 |
| Ahmed, R; Singh, BN | 1 |
| Lüderitz, B; Manz, M | 1 |
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| Nora, M; Zipes, DP | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
| McRitchie, RJ; Roberts-Thomson, P; Twidale, N | 1 |
| Campbell, TJ | 2 |
| Roden, DM | 2 |
| Candinas, R; Follath, F; Frielingsdorf, J | 1 |
| Hohnloser, SH; Singh, BN | 1 |
| Brooks, MM; Hallstrom, A; Peckova, M | 1 |
| Chatelain, P; Finance, O; Manning, A | 1 |
| Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J | 1 |
| Sanderson, J | 1 |
| Lazzara, R | 1 |
| Aiba, T; Kamakura, S | 1 |
| DiMarco, JP; Jung, F | 1 |
| Block, M; Böcker, D; Borggrefe, M; Breithardt, G | 1 |
| Scholz, H | 1 |
| Block, M; Böcker, D; Borggrefe, M; Breithardt, G; Haverkamp, W | 1 |
| Fries, R; Heisel, A; Jung, J; Ozbek, C; Schieffer, H; Sen, S; Stopp, M | 1 |
| Alessandrini, RS; Goldberger, JJ; Kadish, AH; Kane, BJ; McPherson, DD | 1 |
| Bahawar, H; Berkowitsch, A; Michel, U; Neuzner, J; Pitschner, HF; Schlepper, M | 1 |
| McAlister, FA; Teo, KK | 1 |
| Delfaut, P; Giorgberidze, I; Kolettis, T; Krol, RB; Lewis, CB; Mathew, P; Munsif, AN; Prakash, A; Saksena, S; Varanasi, S | 1 |
| Antolini, R; Bova, S; Ferrari, M; Nollo, G; Padrini, R; Piovan, D; Speranza, G | 1 |
| Fogoros, RN | 1 |
| Kuhn, RJ; Luedtke, SA; McCaffrey, FM | 1 |
| Dorian, P; Greene, M; Nanthakumar, K; Newman, D; Paquette, M; Rakovich, G | 1 |
| Doig, JC | 1 |
| Daniels, CJ; Franklin, WH; Hammond, S; Schutte, DA | 1 |
| Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ | 1 |
| Beyer, ME; Hoffmeister, HM; Seipel, L | 1 |
| Borggrefe, M; Breithardt, G; Eckardt, L; Haverkamp, W | 1 |
| MacNeil, DJ | 1 |
| Behrens, S; Franz, MR; Hohnloser, SH; Woosley, RL; Zabel, M | 1 |
| Basta, M; Klein, GJ; Krahn, A; Lee, J; Yee, R | 1 |
| Cilliers, AM; Clur, SA; Dateling, F; du Plessis, JP; Levin, SE | 1 |
| Duytschaever, M; Haerynck, F; Jordaens, L; Tavernier, R | 1 |
| Igoumenidis, NE; Kanoupakis, EM; Kochiadakis, GE; Marketou, ME; Solomou, MC; Vardas, PE | 1 |
| Ikeda, Y; Kimura, M; Kosuge, K; Nakashima, M; Nishimoto, M; Ohashi, K; Umemura, K | 1 |
| Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC | 1 |
| Marchlinski, FE; Movsowitz, C | 1 |
| Ayers, GM; Lau, CP; Tse, HF | 1 |
| Peters, NS | 1 |
| Byth, K; Cooper, MJ; Eipper, V; Kovoor, P; Ross, DL; Uther, JB | 1 |
| Cinca, J; Ferrari, R; Marber, M | 1 |
| Dörnberger, V; Kühlkamp, V; Mermi, J; Mewis, C; Seipel, L; Suchalla, R | 1 |
| Brügemann, J; Crijns, HJ; De Kam, PJ; Tuinenburg, AE; Van Den Berg, MP; Van Gelder, IC | 1 |
| Aurier, E; Bartoletti, A; Caponi, D; Carboni, A; Contini, S; Favaro, L; Finardi, A; Gherli, T; Lepera, G; Maranga, SS; Naccarella, F; Rolli, A | 1 |
| Adinolfi, E; Avella, A; Dini, P; Laurenzi, F | 1 |
| Morady, F | 1 |
| Sager, PT | 1 |
| Charpentier, F; Coutris, G; Merot, J; Poirier, JM; Weissenburger, J | 1 |
| Connolly, S; Dorian, P; Dubuc, M; Eisenberg, MJ; Gagné, P; Green, M; Kus, T; Lambert, J; Nattel, S; Roy, D; Talajic, M; Thibault, B | 1 |
| Cook, JR; Epstein, AE; Greene, HL; Jadonath, R; Lancaster, S; Marinchak, RA; Pacifico, A; Pinski, SL; Yao, Q | 1 |
| Lewalter, T; Lüderitz, B | 1 |
| Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
| Joseph, AP; Ward, MR | 1 |
| Fisher, NG; Gilbert, TJ | 1 |
| Bänsch, D; Block, M; Böcker, D; Breithardt, G; Brunn, J; Weber, M | 1 |
| Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Simantirakis, EN; Vardas, PE | 1 |
| Aggarwal, A | 1 |
| Akhtar, M; Cooley, R; Sra, J | 1 |
| Couturier, A; Dorian, P; Newman, D; Paquette, M; Roy, D; Talajic, M; Yang, C | 1 |
| Dvorák, R; Konecná, P; Semrád, B | 1 |
| Forney, AJ; Schooff, M | 1 |
| Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K | 1 |
| Chrysostomakis, SI; Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Mavrakis, HE; Vardas, PE | 1 |
| Barbosa, EC; Barbosa, PR; Boghossian, SH; da Rocha, PJ; de Souza Bomfim, A; Filho, FM; Ginefra, P | 1 |
| Epstein, AE; Hallstrom, AP; Jadonath, RL; Lancaster, SE; McAnulty, JH; Mounsey, P; Raitt, MH; Renfroe, EG; Steinberg, JS | 1 |
| Brachmann, J | 1 |
| Reddy, P | 1 |
| Veloso, HH | 1 |
| Sarma, JS; Singh, BN | 1 |
| Suttorp, MJ; Tahapary, GJ | 1 |
| Gellér, L; Horkay, F; Kempa, M; Kiss, O; Lewicka-Nowak, E; Lubiński, A; Merkely, B; Nyikos, G; Swiatecka, G; Szabolcs, Z; Zima, E | 1 |
| Cox, CD; Tsikouris, JP | 1 |
| Farkas, A; Leprán, I; Papp, JG | 1 |
| Bogáts, G; Hála, O; Iost, N; Mátyus, P; Opincariu, M; Papp, JG; Szécsi, J; Szenohradszky, P; Szolnoki, J; Varró, A; Virág, L | 1 |
| Bianconi, L; Castro, A; Santini, M | 1 |
| Lenz, TL; Mohiuddin, SM; Mooss, AN; Wurdeman, RL | 1 |
| Bacchi Reggiani, L; Bartolotti, M; Biffi, M; Boriani, G; Branzi, A; Zannoli, R | 1 |
| Biffi, M; Boriani, G; Branzi, A; Rapezzi, C | 1 |
| Alboni, P; Bongiorni, MG; Botto, GL; Brignole, M; Bruna, C; Gasparini, M; Menozzi, C; Ometto, R; Verlato, R; Vincenti, A | 1 |
| Connolly, SJ; Dorian, P; Green, M; Newman, D; Paquette, M; Roy, D; Talajic, M | 1 |
| Klein, G; Krahn, A; Skanes, AC; Yee, R | 1 |
| Couturier, A; Dubuc, M; Frasure-Smith, N; Gagné, P; Lambert, J; Lumer, GB; Nattel, S; Roy, D; Talajic, M; Thibault, B | 1 |
| Connolly, SJ; Crystal, E; Ginger, TJ; Sleik, K; Yusuf, S | 1 |
| Spivack, C | 1 |
| Heidenreich, PA; Hlatky, MA; Keeffe, B; McDonald, KM | 1 |
| Califf, RM; Criger, DA; Ohman, EM; Topol, EJ; White, HD; Wilcox, RG; Wong, CK | 1 |
| Khairy, P; Nattel, S | 1 |
| Ito, H; Maruyama, T | 1 |
| Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
| Wolbrette, DL | 1 |
| Jalil, E; Kus, T; Mensour, B; Vinet, A | 1 |
| DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W | 1 |
| Friberg, J; Gadsbøll, N | 1 |
| Choucair, W; Greenberg, MD; Karasik, P; Kokkinos, P; Pezzullo, J; Singh, SN; Southard, J; Zimmer, J | 1 |
| Levenson, D | 1 |
| Naik, N; Talwar, KK | 1 |
| Delahaye, S; Dommergues, M; Dumez, Y; Fermont, L; Jouannic, JM; Le Bidois, J; Villain, E | 1 |
| Hennersdorf, MG; Niebch, V; Perings, C; Strauer, BE; Vester, EG; Winter, J | 1 |
| de Paola, AA; Fenelon, G; Friedman, PA; Leite, LR; Silva, GG; Simoes, A | 1 |
| Exner, DV; Klein, GJ | 1 |
| Morozova, OI; Pozdniakova, NV; Shevyrev, VA; Tatarchenko, IP | 1 |
| Ganeeva, ON; Tiroke, A | 1 |
| Todd, DW | 1 |
| Antman, EM; Atwood, JE; Ezekowitz, MD; Falk, RH; Fletcher, RD; Fye, CL; Jacobson, AK; Lewis, HD; Lopez, B; Reda, DJ; Sharma, SC; Singh, BN; Singh, SN; Tang, XC | 1 |
| Aybek, T; Dzemali, O; Moritz, A; Scherer, M; Wimmer-Greinecker, G | 1 |
| Brandts, B; Trappe, HJ; Weismueller, P | 1 |
| Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K | 1 |
| Connolly, SJ; Crystal, E; Healey, J | 1 |
| Khan, MH | 1 |
| Cooper, MJ; Crampton, R; Eipper, V; Guy, D; Kijvanit, P; Ross, DL; Thomas, SP; Wallace, E | 1 |
| Lumer, G; Nattel, S; Roy, D; Talajic, M | 1 |
| Dorian, P; Mangat, I | 1 |
| Bulanova, NA; Kositsyna, IV; Morozova, MN; Tereshchenko, SN; Uteshev, IuA | 1 |
| Mounsey, JP; VerNooy, RA | 1 |
| Blagova, OV; Bogdanova, EA; Nedostup, AV; Platonova, AA | 1 |
| Crystal, E | 1 |
| Auer, J; Berent, R; Eber, B; Hartl, P; Lamm, G; Lassnig, E; Lehner, E; Ng, CK; Puschmann, R; Schwarz, C; Strasser, U; Weber, T | 1 |
| Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G | 1 |
| Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
| Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M | 1 |
| Arcidi, JM; Hilleman, DE; Lenz, TL; Mohiuddin, SM; Mooss, AN; Packard, KA; Rovang, KS; Sugimoto, JT; Wurdeman, RL | 1 |
| Breithardt, G; Eckardt, L; Haverkamp, W; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Wasmer, K | 1 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
| Gerstenfeld, EP; Marchlinski, FE; Nayak, H; Patel, VV; Rajawat, YS | 1 |
| DiDomenico, RJ; Massad, MG | 1 |
| Atwood, JE; Ezekowitz, MD; Fletcher, RD; Harris, CL; Jacobson, AK; Lewis, HD; Lopez, B; Raisch, DW; Reda, DJ; Sharma, SC; Singh, BN; Singh, SN; Tang, XC | 1 |
| Block, JE; Calkins, H; Cher, D; Kocheril, AG; Sharma, AD; Stubbs, HA | 1 |
| Boldueva, SA; Leonova, IA; Olesin, AI; Poloskina, OA; Popik, GS; Shabrov, AV; Sinenko, VI | 1 |
| Ho, AT; Pai, RG; Pai, SM; Timothy, P | 1 |
| Rubinstein, J | 1 |
| Desai, KR | 1 |
| Josephson, ME; Zimetbaum, PJ | 1 |
| Hamzeh, K; Jamil, H; Kabbani, SS; Murad, G; Sabbagh, A | 1 |
| Chaudhry, GM; Haffajee, C; Hoffmeister, P; Orlov, M; Shukla, G | 1 |
| Kowey, PR; Yan, GX | 1 |
| de Paola, AA; Veloso, HH | 1 |
| Scharf, C | 1 |
| Ata, N; Birdane, A; Cavusoglu, Y; Goktekin, O; Gorenek, B; Kudaiberdieva, G; Timuralp, B; Unalir, A | 1 |
| Bailin, S; Champagne, J; Connolly, SJ; Coutu, B; Dorian, P; Fain, ES; Gent, M; Gronefeld, GC; Hohnloser, SH; Roberts, RS; Talajic, M; Thorpe, K | 1 |
| Fujiki, A | 1 |
| Campbell, P; Davies, A; de Belder, MA; Hall, JA; Harcombe, AA; Linker, NJ; Stewart, MJ; Sutton, A; Vijayalakshmi, K; Whittaker, VJ; Wright, RA | 1 |
| Chen, YX; Guo, WL; Huang, CX; Jiang, H; Jin, CR; Liu, ZM; Niu, F; Yang, B | 1 |
| Iavelov, IS | 1 |
| Cruz, L; Hong, R; Yeo, KK | 1 |
| Champagne, J; Connolly, SJ; Dorian, P; Fain, E; Gent, M; Hohnloser, SH; Israel, CW; Roberts, R | 1 |
| Lip, GY; Shantsila, E; Watson, T | 1 |
| Atwood, JE; Dorian, P; Ezekowitz, MD; Fletcher, RD; Harris, CL; Jacobson, AK; Lewis, HD; Lopez, B; Raisch, DW; Reda, DJ; Sharma, SC; Singh, BN; Singh, SN; Tang, XC | 1 |
| Crijns, HJ; Hagens, VE; Rienstra, M; Van Gelder, IC; Van Veldhuisen, DJ | 1 |
| Dunning, J; Nashef, SA; Treasure, T; Versteegh, M | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Mitchell, LB | 2 |
| Augello, G; Greiss, I; Gugliotta, F; Gulletta, S; LiVolsi, L; Manguso, F; Mazzone, P; Paglino, G; Pappone, C; Pappone, N; Radinovic, A; Sala, S; Santagostino, A; Santinelli, V; Sora, N; Vicedomini, G | 1 |
| Atwood, JE; Myers, JN; Reda, DJ; Singh, BN; Singh, SN; Tang, XC | 1 |
| Fodstad, H; Kontula, K; Laitinen-Forsblom, P; Lehtonen, A; Swan, H; Toivonen, L | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| Basso, C; Bobbo, F; Iliceto, S; Maron, BJ; Melacini, P; Thiene, G; Tokajuk, B; Zucchetto, M | 1 |
| Inoue, H; Iwamoto, J | 1 |
| Kluger, J; Shah, SA; White, CM | 1 |
| Reiffel, JA | 1 |
| Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC | 1 |
| Boriani, G; Chiarandà, G; Colletti, A; Di Giovanni, N; Grammatico, A; Gulizia, M; Lisi, F; Mangiameli, S; Orazi, S; Pensabene, O; Piccione, G; Vasquez, L | 1 |
| Fuchs, T; Groysman, R; Meilichov, I | 1 |
| Choi, KJ; Kim, HY; Kim, J; Kim, YH; Lee, CH; Nam, GB; Park, HG; Park, KM | 1 |
| Celestino, D; Elizari, MV; Ferreiro, M; Medei, E; Moro, S; Sicouri, S | 1 |
| Abildstrom, SZ; Folke, F; Friberg, J; Gadsbøll, N; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Poulsen, HE; Rasmussen, S; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
| Sharma, S | 1 |
| Ghiselli, A; Magnanti, M; Magrì, D; Marigliano, V; Matera, S; Mitra, M; Paroli, M; Pasquazzi, E; Piccirillo, G; Schifano, E; Velitti, S | 1 |
| Liakishev, AA | 1 |
| Berdajs, D; Genoni, M; Schurr, UP; Seifert, B; Turina, MI; Wagner, A | 1 |
| Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O | 1 |
| Cuneo, BF | 1 |
| Dabouz, F; Ducharme, A; Nattel, S; Palardy, M; Racine, N; Roy, D; Talajic, M; Tardif, JC; Tétreault, K; White, M | 1 |
| Maeda, K; Nakagawa, E; Takagi, M; Tatsumi, H; Yoshiyama, M | 1 |
| Reda, D; Singh, BN; Singh, SN; Tang, XC | 1 |
| Bestetti, R; Cardinalli-Neto, A | 1 |
| Arnaoutoglou, C; Chrisopoulos, C; Keivanidou, A; Kirpizidis, C; Krommydas, A; Papanikolaou, G; Tsiptses, K | 1 |
| Lip, GY; Watson, T | 1 |
| Cannom, DS; Estes, NA; Glidden, DV; Marcus, F; Marcus, GM; Polonsky, B; Scheinman, MM; Smith, LM; Zareba, W | 1 |
| Bolderman, RW; Hermans, JJ; Jansen, TS; Maessen, JG; Rademakers, LM; van der Veen, FH; Verheule, S | 1 |
| Földesi, C; Kardos, A; Ladunga, K; Mihálcz, A; Szili-Török, T | 1 |
| Hanon, S; Sato, K; Schweitzer, P; Shimada, YJ | 1 |
| Guo, DL; Liu, TX; Wu, Y; Yan, GX; Zhao, XJ | 1 |
| Inada, K; Koplan, BA; Roberts-Thomson, KC; Seiler, J; Steven, D; Stevenson, WG; Tedrow, UB | 1 |
| Breithardt, G; Camm, J; Crijns, H; Dorian, P; Kowey, PR; Le Heuzey, JY; Pedrazzini, L; Prystowsky, EN; Salette, G; Schwartz, PJ; Torp-Pedersen, C; Weintraub, W | 1 |
| Hobbs, FD; Hodgkinson, J; Taylor, CJ | 1 |
| Davis, EM; Hilleman, DE; Packard, KA | 1 |
| Arya, A; Boodhoo, L; Bordoli, G; Cheek, E; Large, J; Lloyd, GW; Mitchell, A; Patel, NR; Pugh, P; Silberbauer, JS; Sulke, AN; Taggu, W; Vrahimides, J | 1 |
| Biviano, A; Chen, K; Dizon, J; Dizon, S; Ehlert, F; Garan, H; Nazif, T; Vazquez, J; Whang, W | 1 |
| Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M | 1 |
| Kong, DF; Piccini, JP | 1 |
| Apostolakis, S; Lip, GY | 1 |
| Böhm, M; Linz, D; Neuberger, HR; Schotten, U; Wirth, K | 1 |
| Grunnet, M | 1 |
| Breithardt, G; Eckardt, L; Fehr, M; Frommeyer, G; Koopmann, M; Lücke, M; Milberg, P; Osada, N; Stypmann, J; Witte, P | 1 |
| Smith, W | 1 |
| Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP | 1 |
| Breithardt, G; Eckardt, L; Frommeyer, G; Kaiser, D; Milberg, P; Osada, N; Uphaus, T | 1 |
| Baba, A; Breithardt, G; Eckardt, L; Fink, M; Frommeyer, G; Klocke, R; Matsuda, T; Milberg, P; Müller, FU; Nikol, S; Noble, D; Osada, N; Pott, C; Quang, TH; Ruhe, M; Stypmann, J | 1 |
| Jhaveri, M; Kim, MH; Klingman, D; Lin, J; Smith, PJ | 1 |
| Eccleston, DE; Garg, ML; Kumar, S; Lee, G; Morgan, J; Morton, JB; Sparks, PB; Sutherland, F; Voukelatos, J; Wong, J | 1 |
| Goodman, IS; Lu, CJ | 1 |
| Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X | 1 |
| Arsenault, KA; Crystal, E; Healey, JS; Morillo, CA; Nair, GM; Whitlock, RP; Yusuf, AM | 1 |
| Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Uphaus, T | 1 |
| Bouras, G; Deftereos, S; Efremidis, M; Giannopoulos, G; Kaoukis, A; Karageorgiou, S; Katsivas, A; Kossyvakis, C; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C | 1 |
| Fullerton, DA; He, X; Hegland, DD; Hernandez, AF; Klaskala, W; Mathew, JP; Mills, RM; Peterson, ED; Piccini, JP; Steinberg, BA; Zhao, Y | 1 |
| Balsam, P; Kiliszek, M; Kochanowski, J; Koźluk, E; Lodziński, P; Opolski, G; Piątkowska, A; Piątkowski, R; Scisło, P | 1 |
| Anderson, JL; Bunch, TJ | 1 |
| Brette, S; Chiang, CE; Murin, J; Naditch-Brûlé, L; O'Neill, J; Steg, PG | 1 |
| Al-Khatib, SM; Allen-LaPointe, N; Anstrom, KJ; Daubert, JP; DeWald, T; Horton, JR; Lokhnygina, Y; Peterson, ED; Piccini, JP; Shaw, LK; Steinberg, BA; Thomas, K; Wojdyla, DM | 1 |
| Franz, MR; Gray, RA; Karasik, P; Moore, HJ; Singh, SN | 1 |
| Jankovic, SM; Kostic, M; Paunovic, D; Tesic, D | 1 |
| Aliot, EM; Capucci, A; Connolly, S; Crijns, HJ; Guerra, F; Hohnloser, SH; Kowey, PR; Radzik, D; Roy, D | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L | 1 |
| Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y | 1 |
| Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S | 1 |
| Chiba, T; Kondo, N; Takahara, A | 1 |
| Brophy, JM; Johnson, SM | 1 |
| Ahsan, SY; Di Mario, C; Hayward, C; Lyon, AR; Patel, HC; Patel, K; Rowland, E | 1 |
| Crijns, HJ; Olshansky, B; Rienstra, M; Van Gelder, IC | 1 |
| Koyfman, A; Long, B | 1 |
| Ge, H; Jiang, H; Li, X; Liu, H | 1 |
| Alexopoulos, D; Chiladakis, J; Chouchoulis, K; Davlouros, P; Kaza, M; Koutsogiannis, N | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Curtis, LH; Hammill, BG; Mi, X; Pokorney, SD | 1 |
| AbdelWahab, A; Sapp, J | 1 |
| Khan, I; Mariani, JA; Nanayakkara, S; Patel, HC; Raju, H; Voskoboinik, A | 1 |
| Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C | 1 |
| Kerin, NZ | 1 |
| Aguilar, M; Dobrev, D; Guichard, JB; Heijman, J; Nattel, S | 1 |
| Bjeloševič, M; Chalupka, M; Hatala, R; Illíková, V; Olejník, P; Tomko, J | 1 |
| D'Angelo, RN; Goldstein, L; Kalsekar, I; Khanna, R; Rahman, M; Tung, P; Yadalam, S; Yeh, RW; Zimetbaum, PJ | 1 |
| Kittleson, MD; Lee, S | 1 |
| Kapustnick, Y; Lutsenko, R; Sуdorenko, A | 1 |
| Asadourian, V; Howard, TS; Kim, JJ; Lemming, K; Miyake, CY; Patel, R; Pham, TDN; Rochelson, E; Valdés, SO | 1 |
| Kannankeril, PJ; Kikano, S | 1 |
| Charland, S; Faith, L; Ken-Opurum, J; Park, S; Preblick, R; Revel, A; Srinivas, SS; Vadagam, P | 1 |
| Blomström-Lundqvist, C; Camm, AJ; Crotty, C; Fazeli, MS; Kowey, PR; Kreidieh, B; Singh, JP; Turakhia, MP | 1 |
| Daoud, EG; Savona, SJ | 1 |
| Chung, CP; Daugherty, JR; Dickson, AL; Dupont, WD; Hung, AM; Murray, KT; Ray, WA; Smalley, W; Stein, CM; Zimmerman, E | 1 |
| Blomström-Lundqvist, C; Camm, AJ; Din, N; Fan, J; Kabadi, S; Kowey, P; Pundi, K; Rashkin, J; Sandhu, AT; Singh, JP; Turakhia, MP; Wieloch, M | 1 |
92 review(s) available for sotalol and amiodarone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Evaluation; Electric Stimulation; Electrocardiography, Ambulatory; Humans; Prognosis; Recurrence; Sotalol; Tachycardia; Ventricular Fibrillation | 1992 |
The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1992 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
Class III drugs: their effects on arrhythmias and on the QT interval.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Heart Conduction System; Humans; Sotalol | 1992 |
Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Risk Factors; Sotalol; Ventricular Fibrillation | 1990 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
[Long-term drug therapy of reciprocating supraventricular tachycardia: re-examination of a selected series of cases, using computerized programs].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Computers; Digoxin; Humans; Medigoxin; Middle Aged; Oxprenolol; Propafenone; Propiophenones; Sotalol; Tachycardia; Verapamil | 1980 |
Drugs with a class III antiarrhythmic action.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Tosylate; Electrophysiology; Heart Conduction System; Humans; Sotalol | 1982 |
Indications and limitations of class II and III antiarrhythmic drugs in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Randomized Controlled Trials as Topic; Sotalol | 1994 |
Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Sotalol | 1993 |
Comparison of class I and class III action in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Randomized Controlled Trials as Topic; Sotalol | 1993 |
Class III antiarrhythmics in overdose. Presenting features and management principles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biological Availability; Bretylium Compounds; Drug Overdose; Humans; Sotalol | 1993 |
Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Defibrillators, Implantable; Humans; Pilot Projects; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Heart Conduction System; Humans; Sotalol; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Empiric use of amiodarone and sotalol.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; Humans; Sotalol; Tachycardia, Ventricular | 1993 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
[Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Heart Atria; Humans; Sotalol | 1993 |
Expanding indications for the use of Class III agents in patients at high risk for sudden death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Humans; Risk Factors; Sotalol | 1995 |
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Forecasting; Humans; Incidence; Sotalol; Terminology as Topic | 1995 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes | 1996 |
[Class III antiarrhythmic drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Sotalol | 1996 |
Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Flecainide; Humans; Ion Channels; Quinidine; Sotalol; Sulfonamides | 1996 |
Beta-blockers for ventricular arrhythmias: have we underestimated their value?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; Randomized Controlled Trials as Topic; Sotalol; Tachycardia, Ventricular | 1996 |
Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Humans; Randomized Controlled Trials as Topic; Sotalol; Tachycardia; Treatment Outcome | 1997 |
[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Electrocardiography; Heart Conduction System; Humans; Myocardial Infarction; Sotalol; Survival Rate; Tachycardia, Ventricular | 1996 |
[Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Combined Modality Therapy; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Humans; Sotalol; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Antiarrhythmic therapies for the prevention of sudden cardiac death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Sotalol | 1997 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Child, Preschool; Digoxin; Flecainide; Humans; Infant; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1997 |
Drug-induced cardiac arrhythmias: incidence, prevention and management.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Bradycardia; Cisapride; Digitalis Glycosides; Electrocardiography; Gastrointestinal Agents; Histamine H1 Antagonists; Humans; Incidence; Piperidines; Sotalol; Tachycardia, Ventricular; Torsades de Pointes | 1997 |
Controlling cardiac arrhythmias: an overview with a historical perspective.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Defibrillators, Implantable; Heart Failure; Humans; Sotalol; Survival Rate | 1997 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamines; Sotalol; Sulfonamides | 1997 |
Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Heart Arrest; Humans; Randomized Controlled Trials as Topic; Recurrence; Sotalol; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |
Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Myocardial Infarction; Risk Factors; Sotalol; Survival Rate; Torsades de Pointes | 1997 |
The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Heart Failure; Humans; Hypertension; Infant, Newborn; Phenethylamines; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Risk Factors; Sotalol; Sulfonamides; Survival Rate; Torsades de Pointes | 1997 |
Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Calcium Channel Blockers; Digoxin; Electrocardiography; Humans; Potassium Channel Blockers; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1997 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Disease Models, Animal; Dogs; Electric Countershock; Humans; Sotalol | 1998 |
Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Studies; Humans; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left | 1999 |
Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Secondary Prevention; Sotalol; Survival Rate; Tachycardia, Ventricular | 1999 |
Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Postoperative Complications; Sotalol | 1999 |
New advances in class III antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2000 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Randomized Controlled Trials as Topic; Recurrence; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1999 |
The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart Conduction System; Humans; Sotalol | 2000 |
Does prophylaxis against atrial fibrillation after cardiac surgery reduce length of stay or hospital costs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Costs and Cost Analysis; Hospitalization; Humans; Length of Stay; Randomized Controlled Trials as Topic; Sotalol | 2001 |
Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dronedarone; Electrocardiography; Electrophysiology; Heart; Humans; Ion Channels; Pacemaker, Artificial; Sotalol | 2001 |
A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2001 |
New antiarrhythmic drugs for the treatment of atrial fibrillation.
Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2002 |
Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Postoperative Complications; Randomized Controlled Trials as Topic; Sotalol | 2002 |
Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Humans; Length of Stay; Randomized Controlled Trials as Topic; Risk Factors; Sotalol; Stroke | 2002 |
Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Sotalol | 2002 |
New insights into the mechanisms and management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Humans; Practice Guidelines as Topic; Propafenone; Sotalol; Warfarin | 2002 |
[Recent findings on the dromotropic actions of the class III antiarrhythmic agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Neural Conduction; Pyrimidinones; Sotalol | 2002 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Risk Assessment; Risk Factors; Sex Factors; Sotalol; Sulfonamides; Tachycardia; Torsades de Pointes | 2003 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2003 |
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Hospital Costs; Humans; Length of Stay; Postoperative Complications; Sotalol; Stroke | 2003 |
Identification and management of ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Diagnosis, Differential; Electrocardiography; Humans; Prognosis; Sotalol; Tachycardia, Ventricular | 2003 |
A review of the class III antiarrhythmic agents and their uses and implications for patient management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Humans; Sotalol | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Critical Care; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Hemodynamics; Humans; Lidocaine; Sotalol; Tachycardia; Tachycardia, Ventricular | 2003 |
Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Humans; Incidence; Length of Stay; Postoperative Care; Postoperative Complications; Sotalol | 2003 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; Propafenone; Sotalol | 2003 |
[Chronic heart failure and atrial fibrilation: aspects of management].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Electric Countershock; Heart Failure; Humans; Quinidine; Randomized Controlled Trials as Topic; Sotalol; Sympatholytics; Time Factors; Vasodilator Agents | 2003 |
Antiarrhythmic drug therapy of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Flecainide; Humans; Phenethylamines; Sotalol; Sulfonamides | 2004 |
Atrial fibrillation after cardiac surgery: evidence on prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Humans; Incidence; Postoperative Complications; Risk Factors; Sotalol | 2003 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Surgical Procedures; Digoxin; Humans; Postoperative Care; Risk Factors; Sotalol; Tachycardia, Supraventricular | 2005 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bepridil; Drug Therapy, Combination; Humans; Pyrimidinones; Sotalol | 2006 |
Atrial fibrillation post-cardiac surgery: changing perspectives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Endocarditis; Humans; Magnesium; Postoperative Complications; Sotalol | 2006 |
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Evidence-Based Medicine; Humans; Magnesium; Postoperative Care; Sotalol; Thoracic Surgical Procedures | 2006 |
Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Combined Modality Therapy; Endpoint Determination; Heart Atria; Length of Stay; Magnesium; Sotalol | 2007 |
[Pharmacological therapy for atrial fibrillation after cardiac surgery].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Heparin; Humans; Postoperative Complications; Sotalol; Thromboembolism; Time Factors | 2007 |
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Humans; Sotalol; Sulfonamides; Torsades de Pointes | 2007 |
Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Humans; Hydantoins; Imidazolidines; Piperazines; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2007 |
Antiarrhythmic drugs: present and future.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Design; Humans; Hydantoins; Imidazolidines; Ion Channels; Piperazines; Sotalol | 2007 |
Atrial fibrillation (acute onset).
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol | 2008 |
Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Surgical Procedures; Digoxin; Fatty Acids, Omega-3; Hospital Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Period; Sotalol | 2010 |
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome | 2011 |
Atrial fibrillation (acute onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol | 2011 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Humans; Magnesium Compounds; Pericardiectomy; Randomized Controlled Trials as Topic; Sotalol; Tachycardia, Supraventricular | 2013 |
Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzofurans; Defibrillators, Implantable; Humans; Hydantoins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Mineralocorticoid Receptor Antagonists; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2014 |
Rate control in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Calcium Channel Blockers; Cardiac Resynchronization Therapy; Catheter Ablation; Digoxin; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Pacemaker, Artificial; Patient-Centered Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sotalol | 2016 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Electric Countershock; Humans; Randomized Controlled Trials as Topic; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2017 |
Intravenous Sotalol: An Under Used Treatment Strategy.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Sotalol | 2018 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Heart Atria; Heart Rate; Humans; Myocardial Ischemia; Postoperative Complications; Practice Guidelines as Topic; Sotalol | 2019 |
Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Network Meta-Analysis; Sotalol | 2023 |
61 trial(s) available for sotalol and amiodarone
| Article | Year |
|---|---|
Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Random Allocation; Sotalol; Stroke Volume | 1989 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Time Factors | 1994 |
Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.
Topics: Amiodarone; Cross-Over Studies; Defibrillators, Implantable; Humans; Prospective Studies; Quality of Life; Research Design; Sotalol; Survival Analysis; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
Topics: Aged; Amiodarone; Analysis of Variance; Chi-Square Distribution; Electrophysiology; Female; Humans; Male; Middle Aged; Prospective Studies; Sotalol; Tachycardia, Ventricular | 1994 |
Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Heart Ventricles; Hemodynamics; Humans; Monitoring, Intraoperative; Prospective Studies; Sotalol | 1994 |
Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Defibrillators, Implantable; Humans; Pilot Projects; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Usefulness of sotalol for life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Procainamide; Sotalol | 1993 |
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Confounding Factors, Epidemiologic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Sotalol; Survival Rate; Tachycardia, Ventricular; Treatment Outcome | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Resuscitation; Sotalol; Statistics, Nonparametric; Survival Analysis; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |
Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Recurrence; Safety; Sotalol; Stroke Volume; Treatment Outcome | 1998 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil | 1998 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Disease Models, Animal; Dogs; Electric Countershock; Humans; Sotalol | 1998 |
Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cross-Over Studies; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left | 1999 |
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Female; Humans; Male; Middle Aged; Propafenone; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Sotalol | 2000 |
Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Prognosis; Prospective Studies; Registries; Sotalol; Survival Rate; Tachycardia, Ventricular | 2000 |
A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Topics: Aged; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digoxin; Electric Countershock; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Prospective Studies; Sotalol | 2000 |
Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Single-Blind Method; Sotalol | 2000 |
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Personality; Propafenone; Quality of Life; Severity of Illness Index; Sex Factors; Sotalol; Surveys and Questionnaires | 2000 |
Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Humans; Sotalol; Treatment Outcome | 2000 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol | 2000 |
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Risk Factors; Sotalol; Treatment Outcome | 2000 |
Shortening the second phase duration of biphasic shocks: effects of class III antiarrhythmic drugs on defibrillation efficacy in humans.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Humans; Male; Middle Aged; Prospective Studies; Sotalol; Time Factors | 2001 |
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Echocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Pacemaker, Artificial; Propafenone; Prospective Studies; Quality of Life; Sotalol; Time Factors | 2002 |
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Health Status Indicators; Humans; Male; Mental Health; Propafenone; Quality of Life; Recurrence; Regression Analysis; Severity of Illness Index; Sotalol | 2002 |
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Costs and Cost Analysis; Female; Humans; Male; Middle Aged; Propafenone; Sotalol | 2002 |
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Hospitalization; Humans; Male; Myocardial Infarction; Prospective Studies; Sotalol; Treatment Outcome | 2002 |
Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation: a randomised comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Creatine Kinase; Electric Countershock; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Random Allocation; Recurrence; Severity of Illness Index; Sotalol; Time Factors; Treatment Outcome; Troponin T | 2003 |
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Endpoint Determination; Humans; Sotalol | 2003 |
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Heart Rate; Humans; Male; Sotalol | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome | 2003 |
Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Female; Humans; Infusions, Intravenous; Linear Models; Male; Middle Aged; Sotalol; Statistics, Nonparametric | 2004 |
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Health Status Indicators; Humans; Propafenone; Prospective Studies; Quality of Life; Recurrence; Sotalol | 2003 |
A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Metoprolol; Middle Aged; Pilot Projects; Postoperative Complications; Premedication; Sotalol | 2004 |
Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary Artery Bypass; Double-Blind Method; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Postoperative Complications; Sotalol | 2004 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind Method; Exercise Tolerance; Female; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Quality of Life; Secondary Prevention; Sotalol | 2005 |
Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Quality of Life; Sotalol; Surveys and Questionnaires; Treatment Outcome | 2005 |
Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Prospective Studies; Recurrence; Sotalol | 2006 |
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Equipment Failure; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Sotalol; Ventricular Fibrillation | 2006 |
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Prospective Studies; Sotalol; Treatment Outcome | 2006 |
[Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Electrocardiography, Ambulatory; Exanthema; Female; Follow-Up Studies; Humans; Male; Middle Aged; Sotalol; Treatment Outcome | 2006 |
[Implantable cardioverter defibrillator does not eliminate need for antiarrhythmic drugs in secondary prevention of life threatening ventricular arrhythmias. Results of OPTIC trial].
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Electric Countershock; Female; Health Services Needs and Demand; Humans; Male; Sotalol; Treatment Outcome; Ventricular Fibrillation | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Combined Modality Therapy; Defibrillators, Implantable; Female; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Sotalol; Ventricular Fibrillation; Ventricular Function, Left | 2006 |
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy.
Topics: Activities of Daily Living; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Quality of Life; Severity of Illness Index; Sotalol; Veterans | 2006 |
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Death, Sudden, Cardiac; Diabetes Mellitus; Digitalis Glycosides; Electric Countershock; Fatigue; Female; Flecainide; Follow-Up Studies; Humans; Male; Myocardial Infarction; Netherlands; Proportional Hazards Models; Risk Factors; Secondary Prevention; Sotalol | 2006 |
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Catheter Ablation; Dose-Response Relationship, Drug; Female; Flecainide; Follow-Up Studies; Hospitalization; Humans; Hypertension; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Prognosis; Pulmonary Veins; Retreatment; Sotalol; Stroke Volume; Treatment Failure | 2006 |
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electric Countershock; Exercise Tolerance; Female; Heart Rate; Humans; Male; Sotalol | 2007 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Odds Ratio; Outcome and Process Assessment, Health Care; Sotalol; Thyroid Diseases; Thyroxine | 2007 |
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Probability; Propafenone; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Sotalol; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |
Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Electric Injuries; Female; Heart Failure; Humans; Lung Diseases; Male; Middle Aged; Shock; Sotalol | 2008 |
Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Beverages; Cardiomyopathy, Dilated; Citrus paradisi; Double-Blind Method; Electrocardiography; Female; Heart Conduction System; Humans; Hypertension; Long QT Syndrome; Male; Middle Aged; Sotalol | 2008 |
[Circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. Results of the APAF trial].
Topics: Adolescent; Adult; Aged; Amiodarone; Angina, Unstable; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Pulmonary Veins; Sotalol; Tachycardia, Paroxysmal; Treatment Outcome | 2008 |
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Diltiazem; Female; Humans; Incidence; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Single-Blind Method; Sotalol; Treatment Outcome; Turkey | 2008 |
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Humans; Male; Middle Aged; Multivariate Analysis; Propafenone; Prospective Studies; Renin; Renin-Angiotensin System; Secondary Prevention; Sotalol | 2008 |
The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Female; Humans; Male; Middle Aged; Pyrimidinones; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 2008 |
Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Regression Analysis; Risk Factors; Sotalol; Treatment Outcome | 2009 |
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Glycosides; Cardiotonic Agents; Clinical Competence; Female; Flecainide; Health Care Surveys; Health Knowledge, Attitudes, Practice; Heart Rate; Humans; Internationality; Male; Middle Aged; Practice Guidelines as Topic; Propafenone; Prospective Studies; Registries; Sotalol; Surveys and Questionnaires | 2010 |
Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Confidence Intervals; Dietary Supplements; Electric Countershock; Fatty Acids, Omega-3; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Sotalol; Time Factors | 2012 |
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Propafenone; Sotalol; Sympatholytics; Treatment Outcome | 2013 |
Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Linear Models; Male; Middle Aged; Multivariate Analysis; Poland; Prospective Studies; Pulmonary Veins; Recurrence; Risk Factors; Sotalol; Time Factors; Treatment Outcome | 2014 |
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Coronary Artery Disease; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; North Carolina; Retrospective Studies; Sotalol; Survival Rate; Treatment Outcome | 2014 |
172 other study(ies) available for sotalol and amiodarone
| Article | Year |
|---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
Topics: Action Potentials; Administration, Oral; Aged; Amiodarone; Cardiac Pacing, Artificial; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Potassium Channels; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Right | 1992 |
[Combination anti-arrhythmic drug therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography, Ambulatory; Encainide; Flecainide; Humans; Mexiletine; Sotalol; Tachycardia; Tocainide | 1992 |
Sotalol-induced torsade de pointes: management with magnesium infusion.
Topics: Aged; Amiodarone; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Humans; Magnesium Sulfate; Recurrence; Sotalol; Torsades de Pointes | 1992 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic | 1992 |
Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.
Topics: Action Potentials; Amiodarone; Animals; Bretylium Compounds; Membrane Potentials; Rabbits; Sinoatrial Node; Sotalol | 1991 |
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Topics: Actuarial Analysis; Aged; Amiodarone; Analysis of Variance; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Drug Administration Schedule; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Quinidine; Recurrence; Sotalol | 1991 |
Serious interactions of sotalol with amiodarone and flecainide.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Flecainide; Humans; Hypotension; Male; Middle Aged; Sotalol | 1990 |
Arrhythmogenic effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil | 1990 |
New hope in atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Quinidine; Sotalol | 1990 |
Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts.
Topics: Acetylglucosaminidase; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Female; Heart Rate; In Vitro Techniques; Lysosomes; Male; Mitochondria, Heart; Piperidines; Pyridines; Sotalol | 1990 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle of His; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Electrocardiography; Heart Conduction System; Humans; Ion Channels; Long QT Syndrome; Purkinje Fibers; Sotalol; Wolff-Parkinson-White Syndrome | 1985 |
Inadvertent catheter-induced right bundle branch block in a patient with preexistent left bundle branch block and recurrent macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Bundle-Branch Block; Cardiac Catheterization; Electric Stimulation; Electrocardiography; Heart Ventricles; Humans; Male; Recurrence; Sotalol; Tachycardia | 1989 |
Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.
Topics: Actomyosin; Amiodarone; Animals; Anti-Arrhythmia Agents; Bepridil; Calcium; Calmodulin; Guinea Pigs; Imidazoles; Kinetics; Male; Phosphodiesterase Inhibitors; Protein Kinase C; Quaternary Ammonium Compounds; Sotalol | 1989 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Electrocardiography; Heart Atria; Heart Ventricles; Humans; Quinidine; Sotalol; Systole; Tachycardia | 1985 |
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations.
Topics: Acecainide; Action Potentials; Amiodarone; Arrhythmias, Cardiac; Depression, Chemical; Electrocardiography; Heart; Heart Atria; Heart Ventricles; Humans; Sotalol; Systole | 1985 |
An improved method to correct the QT interval of the electrocardiogram for changes in heart rate.
Topics: Amiodarone; Animals; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Rate; In Vitro Techniques; Male; Scopolamine; Sotalol | 1989 |
Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Female; Heart Conduction System; Humans; Male; Middle Aged; Sotalol; Tachycardia, Supraventricular | 1989 |
Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Female; Follow-Up Studies; Humans; Male; Middle Aged; Sotalol; Tachycardia; Ventricular Fibrillation | 1988 |
Arrhythmogenesis--a European perspective.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Utilization; Europe; Humans; Mexiletine; Sotalol; United States | 1987 |
New anti-arrhythmia. Part II.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Sotalol | 1987 |
Replacement of amiodarone by sotalol for repetitive ventricular premature beats.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sotalol | 1984 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cohort Studies; Coronary Disease; Drug Evaluation; Electrocardiography; Female; Forecasting; Humans; Male; Middle Aged; Prospective Studies; Refractory Period, Electrophysiological; Sotalol; Stroke Volume; Tachycardia, Ventricular; Ventricular Function, Right | 1994 |
AVID necessity.
Topics: Amiodarone; Arrhythmias, Cardiac; Bias; Clinical Trials as Topic; Defibrillators, Implantable; Ethics, Medical; Humans; Patients; Research Design; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Differences in amiodarone, digoxin, flecainide and sotalol concentrations between antemortem serum and femoral postmortem blood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Femoral Artery; Femoral Vein; Flecainide; Humans; Male; Postmortem Changes; Sotalol | 1995 |
AVID necessity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart Ventricles; Humans; Multicenter Studies as Topic; Sotalol | 1993 |
Comparative haemodynamic effects of verapamil, flecainide, amiodarone and sotalol in the conscious rabbit.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Autonomic Nerve Block; Autonomic Nervous System; Cardiac Output; Cardiac Pacing, Artificial; Consciousness; Flecainide; Heart; Heart Atria; Heart Rate; Hemodynamics; Male; Rabbits; Sotalol; Verapamil | 1994 |
Arrhythmogenic actions of class III antiarrhythmic drugs in spontaneously beating rabbit sino-atrial node cells.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Calcium; Cytosol; Fura-2; In Vitro Techniques; Membrane Potentials; Microelectrodes; Myocardial Contraction; Rabbits; Sinoatrial Node; Sotalol | 1993 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinations; Female; Humans; Male; Middle Aged; Quinidine; Sotalol; Tachycardia; Torsades de Pointes; Ventricular Fibrillation | 1994 |
Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol.
Topics: Amiodarone; Animals; Depression, Chemical; Hemodynamics; Male; Myocardial Contraction; Rabbits; Sotalol; Stereoisomerism | 1993 |
Class III antiarrhythmic action: the way forward?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1993 |
A simulation study used to design the sequential monitoring plan for a clinical trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Computer Simulation; Decision Making; Defibrillators, Implantable; Humans; Multicenter Studies as Topic; Pilot Projects; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sotalol; Statistics, Nonparametric; Survival Analysis; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 1995 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Death, Sudden, Cardiac; Disease Models, Animal; Dronedarone; Female; Lidocaine; Male; Myocardial Ischemia; Sotalol; Stereoisomerism; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Heart Block; Heart Rate; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Random Allocation; Rats; Sotalol; Ventricular Fibrillation | 1995 |
The SWORD of Damocles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Sotalol | 1996 |
The coming of age of the class III antiarrhythmic principle: retrospective and future trends.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiology; Heart Conduction System; Humans; Myocardial Infarction; Sotalol | 1996 |
From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Defibrillators, Implantable; Digitalis Glycosides; Electric Countershock; Electric Stimulation; Electrodes, Implanted; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Atria; Humans; Male; Middle Aged; Safety; Sotalol; Stroke Volume; Tachycardia; Ventricular Function, Left | 1997 |
Cardiac memory: a mechanical and electrical phenomenon.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Electrocardiography; Equipment Design; Female; Heart; Humans; Male; Memory; Middle Aged; Models, Cardiovascular; Pacemaker, Artificial; Sotalol; Time Factors; Ventricular Function, Left; Warfarin | 1997 |
Clinical predictors of defibrillation energy requirements.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Coronary Disease; Defibrillators, Implantable; Electric Countershock; Electrophysiology; Equipment Design; Female; Forecasting; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Regression Analysis; Sex Factors; Sotalol; Stroke Volume; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 1997 |
Adaptation of the QT interval to heart rate changes in isolated perfused guinea pig heart: influence of amiodarone and D-sotalol.
Topics: Adaptation, Physiological; Amiodarone; Animals; Anti-Arrhythmia Agents; Electric Stimulation; Electrocardiography; Female; Guinea Pigs; Half-Life; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Sotalol | 1997 |
Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bias; Death, Sudden, Cardiac; Defibrillators, Implantable; Ethics, Medical; Humans; Randomized Controlled Trials as Topic; Research Design; Sotalol; Tachycardia, Ventricular | 1997 |
Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Circadian Rhythm; Female; Humans; Incidence; Male; Metoprolol; Middle Aged; Regression Analysis; Sotalol; Tachycardia, Ventricular | 1997 |
Acute pulmonary toxicity in an infant from intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Bronchoalveolar Lavage Fluid; Dobutamine; Humans; Infant; Infant, Newborn; Injections, Intravenous; Lung Diseases; Macrophages; Male; Microscopy, Electron; Respiratory Insufficiency; Sotalol; Tachycardia | 1997 |
Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Heart Conduction System; Hemodynamics; Humans; Male; Myocardial Contraction; Phenethylamines; Rats; Rats, Wistar; Sotalol; Sulfonamides | 1997 |
Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Heart Ventricles; In Vitro Techniques; Quinidine; Rabbits; Sotalol; Ventricular Function | 1997 |
Junctional ectopic tachycardia in six paediatric patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Catheter Ablation; Child; Child, Preschool; Digoxin; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Humans; Infant; Male; Retrospective Studies; Sotalol; Tachycardia, Ectopic Junctional | 1997 |
Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sotalol; Time Factors | 1998 |
Comparison of class II and class III activity of dl-sotalol in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Heart Rate; Humans; Male; Potassium Channel Blockers; Sotalol; Sympatholytics | 1998 |
Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Electric Countershock; Female; Humans; Male; Middle Aged; Prospective Studies; Sotalol; Treatment Outcome | 1999 |
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Heart Conduction System; Humans; Male; Middle Aged; Retrospective Studies; Sotalol | 1999 |
Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Risk; Sotalol; Treatment Failure; Warfarin | 1999 |
Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Cardiac Surgical Procedures; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Defibrillators, Implantable; Electric Stimulation; Follow-Up Studies; Heart Aneurysm; Heart-Lung Transplantation; Humans; Metoprolol; Middle Aged; Prospective Studies; Sotalol; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 1999 |
[Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Clinical Trials as Topic; Defibrillators, Implantable; Electrophysiology; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Meta-Analysis as Topic; Myocardial Infarction; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sotalol; Time Factors; Vasodilator Agents | 1999 |
Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
Topics: Action Potentials; Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Heart; Sotalol; Torsades de Pointes | 1999 |
[Paroxysmal atrial fibrillation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Female; Humans; Middle Aged; Monitoring, Physiologic; Pacemaker, Artificial; Prognosis; Quinidine; Recurrence; Risk Factors; Sotalol; Thromboembolism; Vasodilator Agents | 2000 |
Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Synergism; Echocardiography; Electrocardiography; Fatigue; Humans; Magnetic Resonance Imaging; Male; Sotalol; Syncope | 2000 |
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Heart Transplantation; Humans; Middle Aged; Prognosis; Regression Analysis; Retrospective Studies; Sotalol; Survival Analysis; Tachycardia, Ventricular | 2000 |
Amiodarone to prevent recurrence of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Propafenone; Secondary Prevention; Sotalol | 2000 |
[Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1999 |
The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Recurrence; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Sotalol; Treatment Outcome | 2001 |
"Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Controlled Clinical Trials as Topic; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Registries; Risk; Sotalol; Tachycardia, Ventricular | 2001 |
Comparison of class III antiarrhythmic drugs versus digoxin for the reversion of new-onset atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Humans; Sotalol; Time Factors; Treatment Outcome | 2001 |
Oral amiodarone and atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Patient Selection; Propranolol; Sotalol; Tachycardia, Supraventricular; Treatment Outcome | 2001 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Heart Rate; Infusions, Intravenous; Male; Phenylephrine; Propanolamines; Quinidine; Rabbits; Sotalol; Torsades de Pointes | 2002 |
The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
Topics: Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Electric Stimulation; Electrophysiology; Female; Heart; Humans; In Vitro Techniques; Kinetics; Male; Mexiletine; Papillary Muscles; Phenethylamines; Sotalol; Sulfonamides; Ventricular Function, Right | 2002 |
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Male; Middle Aged; Recurrence; Regression Analysis; Sotalol; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Combined Modality Therapy; Defibrillators, Implantable; Differential Threshold; Echocardiography, Doppler; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Long-Term Care; Male; Risk Assessment; Severity of Illness Index; Sotalol | 2002 |
Amiodarone: pearl or peril?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Humans; Propafenone; Sotalol | 2002 |
Implantable cardiac defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Humans; Myocardial Infarction; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Research Design; Sotalol; Treatment Outcome | 2003 |
Findings suggest revised atrial fibrillation approach.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Disease Management; Electric Countershock; Heart Rate; Humans; Practice Guidelines as Topic; Sotalol; Treatment Outcome; United States | 2003 |
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Echocardiography; Female; Fetal Diseases; Flecainide; Gestational Age; Heart Rate, Fetal; Humans; Hydrops Fetalis; Infant, Newborn; Pregnancy; Pregnancy Outcome; Prenatal Care; Retrospective Studies; Sotalol; Tachycardia, Ectopic Junctional; Tachycardia, Supraventricular; Treatment Outcome; Ultrasonography, Prenatal | 2003 |
Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Mexiletine; Middle Aged; Prognosis; Propafenone; Sotalol; Survivors; Time Factors; Treatment Outcome | 2003 |
Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Brazil; Chagas Cardiomyopathy; Death, Sudden, Cardiac; Drug Therapy, Combination; Electric Stimulation Therapy; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Discharge; Predictive Value of Tests; Proportional Hazards Models; Secondary Prevention; Sotalol; Stroke Volume; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death?
Topics: Amiodarone; Anti-Arrhythmia Agents; Chagas Cardiomyopathy; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Humans; Randomized Controlled Trials as Topic; Risk Factors; Sotalol; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2003 |
[Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Data Interpretation, Statistical; Disopyramide; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Phenothiazines; Sotalol | 2003 |
[Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Defibrillators, Implantable; Electric Countershock; Female; Humans; Male; Middle Aged; Sotalol | 2003 |
Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Chronic Disease; Cohort Studies; Digitoxin; Echocardiography; Electric Countershock; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Sotalol; Survival Analysis; Treatment Outcome; Verapamil | 2003 |
[Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Periodicity; Sotalol; Ventricular Premature Complexes; Verapamil | 2004 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States | 2004 |
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology Service, Hospital; Electric Countershock; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Male; Middle Aged; Prajmaline; Propafenone; Quinidine; Retrospective Studies; Sotalol | 2004 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol | 2004 |
Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
Topics: Action Potentials; Administration, Oral; Amiodarone; Animals; Disease Models, Animal; Drug Administration Schedule; Electrophysiologic Techniques, Cardiac; Heart Block; Heart Conduction System; Long QT Syndrome; Male; Rabbits; Sotalol; Torsades de Pointes | 2004 |
Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Combined Modality Therapy; Defibrillators, Implantable; Drug Interactions; Humans; Hydantoins; Imidazolidines; Pacemaker, Artificial; Piperazines; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2004 |
[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol; Ventricular Dysfunction | 2005 |
Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden, Cardiac; Defibrillators, Implantable; Digoxin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Sotalol; Stroke Volume; Survival Rate | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Quality of Life; Sotalol | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Humans; Lung Diseases; Sotalol | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Sex Factors; Sotalol; Torsades de Pointes | 2005 |
Ablation of atrial fibrillation using microwave energy--early experience.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Coronary Artery Disease; Electric Countershock; Female; Heart Valve Diseases; Humans; Male; Microwaves; Middle Aged; Postoperative Care; Sotalol; Treatment Outcome | 2005 |
Potential proarrhythmic effect of biventricular pacing: fact or myth?
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Defibrillators, Implantable; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Male; Middle Aged; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2005 |
Proarrhythmias and antiarrhythmias: two sides of the same coin.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Defibrillators, Implantable; Humans; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 2005 |
Sotalol and amiodarone versus digoxin for conversion of recent onset atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Humans; Sotalol; Time Factors | 2005 |
Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Coronary Angiography; Defibrillators, Implantable; Electrocardiography; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Sotalol; Tachycardia; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Troponin I | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Finland; Flecainide; Founder Effect; Genetic Predisposition to Disease; Genetic Testing; Heart Conduction System; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Middle Aged; Mutation; Propafenone; Risk Factors; Sotalol; Torsades de Pointes; Treatment Outcome | 2007 |
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Sotalol; Verapamil | 2007 |
Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Medical Records; Middle Aged; Retrospective Studies; Sotalol; Stroke Volume; Treatment Outcome | 2008 |
In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle.
Topics: Action Potentials; Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Dogs; Dronedarone; Endocardium; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Pericardium; Sotalol; Ventricular Function, Left | 2007 |
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Denmark; Digoxin; Drug Therapy; Female; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Patient Discharge; Registries; Retrospective Studies; Sotalol | 2008 |
Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arteries; Atrioventricular Block; Atrioventricular Node; Child; Constriction; Epidemiologic Methods; Female; Heart Conduction System; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Pacemaker, Artificial; Postoperative Complications; Sotalol | 2008 |
Treatment of fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Electrophysiology; Digoxin; Female; Fetal Diseases; Humans; Pregnancy; Sotalol; Tachycardia | 2008 |
Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Defibrillators, Implantable; Humans; Randomized Controlled Trials as Topic; Sotalol; Tachycardia, Ventricular; Trypanosoma cruzi | 2009 |
Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Atrial Fibrillation; Ciprofloxacin; Electric Countershock; Electrocardiography; Female; Heart Arrest; Humans; Long QT Syndrome; Sotalol; Syncope; Torsades de Pointes; Treatment Outcome | 2009 |
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Combined Modality Therapy; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Registries; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2009 |
Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Humans; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2009 |
Intrapericardial delivery of amiodarone and sotalol: atrial transmural drug distribution and electrophysiological effects.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function, Right; Drug Delivery Systems; Electrophysiological Phenomena; Endocardium; Goats; Pericardium; Sotalol; Tissue Distribution; Ventricular Function, Right | 2009 |
[Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Catheter Ablation; Drug Administration Schedule; Female; Follow-Up Studies; Heart Atria; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Propafenone; Pulmonary Veins; Research Design; Sample Size; Sotalol; Tachycardia, Supraventricular; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Hypertrophic; Carvedilol; Continuous Positive Airway Pressure; Defibrillators, Implantable; Heart Failure; Humans; Lung Diseases, Interstitial; Male; Propanolamines; Recurrence; Sleep Apnea Syndromes; Sotalol; Tachycardia, Ventricular | 2009 |
[Effects of chronic amiodarone therapy on L-type calcium current recovery and action potential duration of rabbit ventricular myocytes].
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channels, L-Type; Myocytes, Cardiac; Patch-Clamp Techniques; Rabbits; Sotalol | 2009 |
Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Catheter Ablation; Coronary Artery Disease; Defibrillators, Implantable; Female; Hemodynamics; Humans; Kaplan-Meier Estimate; Male; Massachusetts; Middle Aged; Prognosis; Quality of Life; Sex Factors; Sotalol; Tachycardia, Ventricular; Time Factors; Treatment Failure | 2010 |
Rhythm control agents and adverse events in patients with atrial fibrillation.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sotalol | 2010 |
First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Humans; Male; Recurrence; Retreatment; Retrospective Studies; Sotalol; Tachycardia; Treatment Outcome | 2010 |
Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Dronedarone; Drug Therapy, Combination; Humans; Sotalol | 2010 |
A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Selection; Retrospective Studies; Risk Factors; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 2011 |
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome | 2011 |
Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Male; Models, Animal; Potassium; Potassium Channels, Voltage-Gated; Sleep Apnea, Obstructive; Sotalol; Swine | 2011 |
Pharmacological treatment of atrial fibrillation: what does it take?
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Male; Potassium Channels, Voltage-Gated; Sleep Apnea, Obstructive; Sotalol | 2011 |
A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Female; Heart Conduction System; Heart Failure; Rabbits; Sotalol; Torsades de Pointes | 2011 |
Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Desmosomes; Electrocardiography; Female; Genetic Diseases, Inborn; Heart Arrest; Humans; Male; Mutation; Pedigree; Plakophilins; Practice Guidelines as Topic; Sex Factors; Sotalol; Survival Rate; Tachycardia, Ventricular | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2011 |
Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dronedarone; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Ventricles; In Vitro Techniques; Long QT Syndrome; Perfusion; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Function | 2012 |
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Heart; Heart Failure; Heart Ventricles; Humans; Long QT Syndrome; Rabbits; Sodium-Calcium Exchanger; Sotalol; Tachycardia, Ventricular; Torsades de Pointes; Veratridine | 2012 |
One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Retrospective Studies; Sotalol; Treatment Outcome | 2011 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Infant; Infusions, Intraosseous; Infusions, Intravenous; Male; Procainamide; Propranolol; Recurrence; Sotalol; Tachycardia, Supraventricular; Treatment Failure; Vagus Nerve Stimulation | 2012 |
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabetes Mellitus; Female; Flecainide; Heart Rate; Heart Valve Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Propafenone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Remission Induction; Sotalol; Time Factors; Treatment Outcome | 2013 |
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Female; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sotalol | 2013 |
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Female; Heart Valve Prosthesis Implantation; Humans; Male; Odds Ratio; Sotalol | 2013 |
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Echocardiography; Electrocardiography; Female; Health Surveys; Heart; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Risk Factors; Sotalol | 2014 |
Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
Topics: Action Potentials; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Computer Simulation; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Models, Cardiovascular; Numerical Analysis, Computer-Assisted; Predictive Value of Tests; Prospective Studies; Refractory Period, Electrophysiological; Sodium; Sodium Channel Blockers; Sodium Channels; Sotalol; Tachycardia, Ventricular; Time Factors; Treatment Outcome | 2014 |
Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Disease-Free Survival; Humans; Models, Theoretical; Propafenone; Serbia; Sotalol | 2015 |
Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Sotalol | 2014 |
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol | 2015 |
[Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Child; Child, Preschool; Echocardiography; Electrocardiography; Humans; Infant; Retrospective Studies; Sotalol; Tachycardia, Ectopic Atrial; Tachycardia, Supraventricular; Ventricular Function, Left | 2015 |
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides | 2016 |
Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Bepridil; Cardiac Pacing, Artificial; Disease Models, Animal; Infusions, Intravenous; Male; Pyrrolidines; Rabbits; Sotalol | 2016 |
Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Canada; Comorbidity; Coronary Artery Bypass; Female; Humans; Male; Registries; Retrospective Studies; Sotalol | 2016 |
The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug Prescriptions; Drug Utilization; England; Flecainide; Humans; Retrospective Studies; Sotalol | 2016 |
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Male; Metoprolol; Multivariate Analysis; Propafenone; Retrospective Studies; Sotalol; Tachycardia, Ectopic Atrial; Treatment Outcome | 2017 |
Impact of QT interval prolongation following antiarrhythmic drug therapy on left ventricular function.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Propafenone; Sotalol; Ventricular Function, Left | 2017 |
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Logistic Models; Male; Medicare Part D; Mexiletine; Ranolazine; Sodium Channel Blockers; Sotalol; Tachycardia, Ventricular; United States | 2017 |
Trends in outpatient anti-arrhythmic prescriptions for atrial fibrillation and left atrial ablation in Australia: 1997-2016.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Catheter Ablation; Drug Prescriptions; Female; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Sotalol; Treatment Outcome | 2018 |
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol | 2018 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregnancy; Propafenone; Retrospective Studies; Slovakia; Sotalol; Tachycardia, Supraventricular | 2020 |
Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Flecainide; Humans; Male; Middle Aged; Sotalol; Treatment Outcome; Young Adult | 2021 |
Naturally occurring torsades de pointes and QT interval prolongation in a domestic cat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cat Diseases; Cats; Electrocardiography; Long QT Syndrome; Male; Sotalol; Torsades de Pointes | 2021 |
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Sotalol | 2021 |
Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Heart Defects, Congenital; Humans; Retrospective Studies; Sotalol; Tachycardia, Ectopic Junctional | 2022 |
Sotalol vs amiodarone for postoperative junctional ectopic tachycardia: Citius, Altius, Fortius?
Topics: Amiodarone; Heart Defects, Congenital; Humans; Sotalol; Tachycardia, Ectopic Junctional | 2022 |
A value-based budget impact model for dronedarone compared with other rhythm control strategies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Sotalol | 2023 |
Something Old, Something New: Reinventing Antiarrhythmic Drug Loading With Intravenous Sotalol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Sotalol; Torsades de Pointes | 2023 |
Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Female; Flecainide; Hemorrhage; Hospitalization; Humans; Ischemic Stroke; Male; Medicare; Retrospective Studies; Rivaroxaban; Sotalol; Stroke; United States | 2023 |
Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Sotalol; Stroke Volume; Ventricular Function, Left; Veterans | 2023 |